We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORBC
2226
DELISTED
ORBCOMM, Inc.
ORBC
$285K ﹤0.01%
83,762
+67,438
+413% +$262K
CHGG icon
2227
Chegg
CHGG
$89.3M
$284K ﹤0.01%
3,982
-13,483
-77% -$993K
NBIX icon
2228
Neurocrine Biosciences
NBIX
$15.3B
$284K ﹤0.01%
2,955
+2,564
+656% +$297K
NUMG icon
2229
Nuveen ESG Mid-Cap Growth ETF
NUMG
$376M
$284K ﹤0.01%
6,731
-3,369
-33% -$141K
AC
2230
DELISTED
Associated Capital Group
AC
$283K ﹤0.01%
7,832
+987
+14% +$37.6K
KE
2231
Kimball Electronics
KE
$626M
$283K ﹤0.01%
24,492
+20,017
+447% +$262K
LAND
2232
Gladstone Land Corp
LAND
$358M
$283K ﹤0.01%
18,825
+16,339
+657% +$256K
AFMD
2233
DELISTED
Affimed
AFMD
$282K ﹤0.01%
8,313
+6,773
+440% +$257K
ARTNA icon
2234
Artesian Resources
ARTNA
$369M
$282K ﹤0.01%
8,195
+6,591
+411% +$233K
ISEE
2235
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$282K ﹤0.01%
50,085
+47,848
+2,139% +$228K
DXPE icon
2236
DXP Enterprises
DXPE
$3B
$281K ﹤0.01%
17,407
+14,070
+422% +$260K
LFCR icon
2237
Lifecore Biomedical
LFCR
$179M
$281K ﹤0.01%
28,960
+23,721
+453% +$226K
NVEC icon
2238
NVE Corp
NVEC
$563M
$281K ﹤0.01%
5,722
+4,718
+470% +$261K
OPI
2239
DELISTED
Office Properties Income Trust
OPI
$280K ﹤0.01%
13,514
+10,252
+314% +$247K
WMK icon
2240
Weis Markets
WMK
$1.77B
$280K ﹤0.01%
5,847
+4,997
+588% +$246K
PFIS icon
2241
Peoples Financial Services
PFIS
$717M
$279K ﹤0.01%
8,031
+6,494
+423% +$238K
EZPW icon
2242
Ezcorp Inc
EZPW
$1.76B
$278K ﹤0.01%
55,364
+44,315
+401% +$246K
TDIV icon
2243
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.47B
$278K ﹤0.01%
+6,340
New +$278K
UYG icon
2244
ProShares Ultra Financials
UYG
$863M
$278K ﹤0.01%
9,007
+2,506
+39% +$78.9K
BBD icon
2245
Banco Bradesco
BBD
$34.3B
$277K ﹤0.01%
97,532
+88,854
+1,024% +$291K
SPHR icon
2246
Sphere Entertainment
SPHR
$6.33B
$277K ﹤0.01%
4,043
-2,330
-37% -$168K
VSEC icon
2247
VSE Corp
VSEC
$6.48B
$277K ﹤0.01%
9,058
+7,350
+430% +$217K
NPK icon
2248
National Presto Industries
NPK
$987M
$276K ﹤0.01%
3,366
-718
-18% -$62.7K
ALRS icon
2249
Alerus Financial
ALRS
$844M
$275K ﹤0.01%
14,013
+12,595
+888% +$255K
BLFS icon
2250
BioLife Solutions
BLFS
$1.72B
$275K ﹤0.01%
9,516
+7,745
+437% +$167K
88 89
90
91 92

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.